Carlson Capital’s Boston Scientific BSX Stock Holding History

Carlson Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-40,560	Closed	-$1.55M	–	158
2020 Q3	$1.55M	Sell	40,560 -59,442	-59%	-$2.29M	0.05%	165
2020 Q2	$3.51M	Buy	+100,002	New	+$3.6M	0.1%	138
2019 Q3	–	Sell	-346,736	Closed	-$14.9M	–	236
2019 Q2	$14.9M	Sell	346,736 -198,868	-36%	-$7.65M	0.23%	140
2019 Q1	$20.9M	Sell	545,604 -51,696	-9%	-$1.97M	0.37%	84
2018 Q4	$21.1M	Buy	597,300 +340,000	+132%	+$12.3M	0.33%	89
2018 Q3	$9.91M	Sell	257,300 -342,700	-57%	-$12M	0.12%	186
2018 Q2	$19.6M	Buy	+600,000	New	+$18.1M	0.27%	105
2017 Q3	–	Sell	-781,993	Closed	-$21.7M	–	225
2017 Q2	$21.7M	Buy	781,993 +201,693	+35%	+$5.35M	0.31%	104
2017 Q1	$14.4M	Buy	580,300 +85,760	+17%	+$2.09M	0.18%	152
2016 Q4	$10.7M	Buy	+494,540	New	+$10.8M	0.13%	180

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Carlson Capital's BSX Position: Q4 2020 in Review

Carlson Capital sold out of Boston Scientific (BSX) in Q4 2020, closing a stake of 40,560 shares — an estimated $1.55M sold.

Carlson Capital first reported a position in BSX in Q4 2016 and held it in 10 quarters. The position peaked at $21.7M in Q2 2017. 865 funds tracked by Wall St. Rank hold BSX as of Q4 2020.

Carlson Capital reported no remaining Boston Scientific position as of Q4 2020 after selling out during the quarter.
Carlson Capital sold 40,560 Boston Scientific shares in Q4 2020, an estimated $1.55M.
Carlson Capital first reported a position in Boston Scientific in Q4 2016 and held it in 10 quarters.
Carlson Capital's Boston Scientific position peaked at $21.7M in Q2 2017.
865 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2020.

Based on Carlson Capital's 13F filing for Q4 2020, filed 12 Feb 2021.